Try Fund Library Premium
For Free with a 30 day trial!
Alternative Other
Close (06-20-2025) |
$44.35 |
---|---|
Change |
-$1.51
(-3.29%)
|
Open | $46.46 |
---|---|
Day Range | $43.86 - $46.46 |
Volume | 7,358 |
As at May 31, 2025
As at March 31, 2025
Inception Return (September 26, 2022): 26.78%
Row Heading | Return | Annualized Return | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
Fund | 43.25% | 10.09% | -29.87% | -26.36% | -31.83% | 17.18% | - | - | - | - | - | - | - | - |
Benchmark | 5.56% | 3.87% | 3.54% | 7.05% | 21.05% | 19.29% | 11.55% | 10.63% | 14.92% | 11.89% | 10.58% | 10.22% | 10.45% | 8.99% |
Category Average | 16.55% | -5.69% | -5.69% | -4.31% | 7.77% | 35.26% | 22.54% | 9.79% | 10.04% | 9.35% | 7.64% | 7.28% | 7.30% | 6.25% |
Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Return % | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fund | -10.63% | -2.52% | -24.91% | 3.83% | -0.44% | 43.75% | -4.77% | 0.40% | -33.37% | -17.87% | -6.42% | 43.25% |
Benchmark | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% | 6.37% | -3.27% | 3.48% | -0.40% | -1.51% | -0.10% | 5.56% |
49.85% (February 2024)
-33.37% (February 2025)
Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Fund | - | - | - | - | - | - | - | - | 86.56% | 55.55% |
Benchmark | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% |
Category Average | -0.60% | 6.48% | 4.63% | -4.48% | 6.64% | 14.43% | 7.75% | -45.86% | 66.56% | 58.00% |
Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
Category Rank | - | - | - | - | - | - | - | - | - | - |
86.56% (2023)
55.55% (2024)
Name | Percent |
---|---|
Commodities | 100.00 |
Cash and Equivalents | 0.00 |
Name | Percent |
---|---|
Cash and Cash Equivalent | 0.00 |
Other | 100.00 |
Name | Percent |
---|---|
North America | 0.00 |
Other | 100.00 |
Name | Percent |
---|---|
ETHEREUM | - |
Cash and Cash equivalents | - |
Standard Deviation | - | - | - |
---|---|---|---|
Beta | - | - | - |
Alpha | - | - | - |
Rsquared | - | - | - |
Sharpe | - | - | - |
Sortino | - | - | - |
Treynor | - | - | - |
Tax Efficiency | - | - | - |
Volatility | - | - | - |
Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
---|---|---|---|---|
Standard Deviation | 81.10% | - | - | - |
Beta | 5.10% | - | - | - |
Alpha | -1.11% | - | - | - |
Rsquared | 0.49% | - | - | - |
Sharpe | -0.16% | - | - | - |
Sortino | -0.27% | - | - | - |
Treynor | -0.03% | - | - | - |
Tax Efficiency | - | - | - | - |
Start Date | September 26, 2022 |
---|---|
Instrument Type | Exchange Traded Fund (Alternative) |
Share Class | Do-It-Yourself |
Legal Status | - |
Sales Status | Open |
Currency | CAD |
Distribution Frequency | Annual |
Assets ($mil) | $49 |
52 Week High | $78.39 |
52 Week Low | $27.38 |
Annual Dividend | - |
Annual Yield | - |
Index | - |
Shares Outstanding | - |
Registered Plan Eligible | Yes |
Exposure | - |
---|---|
Asset Class High | - |
Asset Class Medium | - |
Asset Class Low | - |
Leveraged | - |
Inverse | - |
Advisor Series | - |
Covered Call Strategy | No |
Fidelity Advantage Ether ETFâ„¢ aims to invest in ether.
In order to achieve its investment objective, Fidelity Advantage Ether ETFâ„¢ invests primarily in ether. The direct long-term holdings of ether are purchased or received by Fidelity Advantage Ether ETFâ„¢ only from Acceptable Bitcoin/Ether Sources. Each Acceptable Bitcoin/Ether Source is a spot market where ether can be exchanged for U.S. or, in some cases, Canadian dollars.
Portfolio Manager |
Fidelity Investments Canada ULC
|
---|---|
Sub-Advisor |
- |
Fund Manager |
Fidelity Investments Canada ULC |
---|---|
Custodian |
- |
Registrar |
- |
Distributor |
- |
MER | 0.73% |
---|---|
Management Fee | 0.40% |
Try Fund Library Premium
For Free with a 30 day trial!